Brief: Vivesto Enters Agreement With Zhida Pharma For Apealea
Nov 7 (Reuters) - Vivesto AB VIVE.ST :
* ENTERS AGREEMENT WITH ZHIDA PHARMA FOR APEALEA
* LICENSE AGREEMENT INCLUDES MILESTONE PAYMENTS UP TO USD
5.85
MILLION
Source text: ID:nMFN7MkTw1
Further company coverage: VIVE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Vivesto AB
See all newsBrief: Vivesto Reports Positive Topline Results From Paccal Vet Study In Cats
Brief: Vivesto Says Topline Results For Paccal Vet 'Positive'
Brief: Vivesto Q2 Operating Loss At SEK 8.6 Mln
Brief: Vivesto: Positive Results From Exploratory Study With Cantrixil
Brief: Vivesto Appoints Björn Svanström As CFO